Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
1,268
1,268 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- WJ22096Phase 21 trial
Nanjing Jingao biomidical technology Co. Ltd. · Advanced Solid Tumors
- WTX-330Phase 21 trial
Werewolf Therapeutics, Inc. · Advanced or Metastatic Solid Tumors, Non-Hodgkin Lymphoma
- XER-001Phase 21 trial
Xerient Pharma · Locally Advanced Pancreatic Adenocarcinoma, Locally Advanced Pancreas Cancer, Locally Advanced Pancreatic Ductal Adenocarcinoma
- XNW29016PARGiPhase 21 trial
Evopoint Biosciences Inc. · Tumor, Solid
- XNW34017Phase 21 trial
Evopoint Biosciences Inc. · Advanced Solid Tumors
- XP-102Phase 21 trial
Xynomic Pharmaceuticals, Inc. · Cancer, BRAF V600 Mutation, Melanoma
- XS-03Phase 21 trial
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. · Colorectal Cancer, Metastatic Colorectal Cancer With RAS Mutation
- XTX202Phase 21 trial
Xilio Development, Inc. · Advanced Solid Tumor
- XTX301Phase 21 trial
Xilio Development, Inc. · Advanced Solid Tumor
- XTX501Phase 21 trial
Xilio Development, Inc. · Metastatic NSCLC - Non-Small Cell Lung Cancer, Advanced Solid Tumor
- XYA02Phase 21 trial
XYone Therapeutics, Inc · MUC1-expressing Advanced, Relapsed and/or Refractory Solid Tumors, Non-Small Cell Lung Cancer, Ovarian Cancer
- XZP-5955Phase 21 trial
Xuanzhu Biopharmaceutical Co., Ltd. · Locally Advanced or Metastatic Solid Tumors, Locally Advanced or Metastatic Non-small Cell Lung Cancer
- Y101DPhase 21 trial
Wuhan YZY Biopharma Co., Ltd. · Advanced Pancreatic Adenocarcinoma
- YH32364Phase 21 trial
Yuhan Corporation · EGFR Overexpression, Locally Advanced Solid Tumor, Metastatic Solid Tumor
- YH32367Phase 21 trial
Yuhan Corporation · HER2-Positive Solid Tumor
- YH42946Phase 21 trial
Yuhan Corporation · NSCLC (Non-small Cell Lung Cancer), Solid Tumor
- YL-13027Phase 21 trial
Shanghai YingLi Pharmaceutical Co. Ltd. · Metastatic Pancreatic Cancer
- ZL-85FAPhase 21 trial
Chengdu Zenitar Biomedical Technology Co., Ltd · Advanced Solid Tumor
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.